Company: TELO
Filing Date: 2025-02-26
Form Type: CORRESP
Source: 0001493152-25-008285
Chunk: 0

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-26
Form: CORRESP
Chunk 0
---
<div align='center'>Telomir Pharmaceuticals, Inc.

100 SE 2nd St, Suite 2000, #1009

Miami, Florida</div>

February 26, 2025

VIA EDGAR

U.S. Securities & Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

| Re: | Telomir Pharmaceuticals, 
 Inc.                     |
|     | Registration Statement   
 on Form S-3              |
|     | File No. 333-284990      |

Ladies and Gentlemen:

In accordance with Rule 461 of the Securities Act of 1933, as amended, Telomir Pharmaceuticals, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 9:00 a.m. Eastern Time on Friday, February 28, 2025, or as soon thereafter as possible.

<div align='center'>* * * *</div>

Very Truly Yours,

| Telomir Pharmaceuticals, Inc. |
| /s/ Erez                      
 Aminov                        |
| Erez Aminov                   |
| Chief Executive Officer       |